|
1
|
Ohgaki H: Epidemiology of brain tumors.
Methods Mol Biol. 472:323–342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stylli SS and Kaye AH: Photodynamic
therapy of cerebral glioma-a review. Part II-clinical studies. J
Clin Neurosci. 13:709–717. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pan DS, Feng SZ, Cao P and Li JJ:
Endothelin B receptor promotes the proliferation and immune escape
of malignant gliomas. Artif Cells Nanomed Biotechnol. 46:1230–1235.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ruokun C, Yake X, Fengdong Y, Xinting W,
Laijun S and Xianzhi L: Lentivirus-mediated silencing of HSDL2
suppresses cell proliferation in human gliomas. Tumour Biol.
37:15065–15077. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang L, Wang C, Lei F, Zhang L, Zhang X,
Liu A, Wu G, Zhu J and Song L: miR-93 promotes cell proliferation
in gliomas through activation of PI3K/Akt signaling pathway.
Oncotarget. 6:8286–8299. 2015.PubMed/NCBI
|
|
8
|
Pan Y, Liang W, Zhao X, Liu L, Qing Y and
Li Y: miR-548b inhibits the proliferation and invasion of malignant
gliomas by targeting metastasis tumor-associated protein-2.
Neuroreport. 27:1266–1273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liang ML, Hsieh TH, Ng KH, Tsai YN, Tsai
CF, Chao ME, Liu DJ, Chu SS, Chen W, Liu YR, et al: Downregulation
of miR-137 and miR-6500-3p promotes cell proliferation in pediatric
high-grade gliomas. Oncotarget. 7:19723–19737. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Catanzaro G, Besharat ZM, Miele E,
Chiacchiarini M, Po A, Carai A, Marras CE, Antonelli M, Badiali M,
Raso A, et al: The miR-139-5p regulates proliferation of
supratentorial paediatric low-grade gliomas by targeting the
PI3K/AKT/mTORC1 signalling. Neuropathol Appl Neurobiol. 44:687–706.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang G, Kang C and Pu P: Increased
expression of Akt2 and activity of PI3K and cell proliferation with
the ascending of tumor grade of human gliomas. Clin Neurol
Neurosurg. 112:324–327. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leslie K, Lang C, Devgan G, Azare J,
Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, et al:
Cyclin D1 is transcriptionally regulated by and required for
transformation by activated signal transducer and activator of
transcription 3. Cancer Res. 66:2544–2552. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang X, Zhao M, Huang AY, Fei Z, Zhang W
and Wang XL: The effect of cyclin D expression on cell
proliferation in human gliomas. J Clin Neurosci. 12:166–168. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu S, Fu J, Dong Y, Yi Q, Lu D, Wang W, Qi
Y, Yu R and Zhou X: GOLPH3 promotes glioma progression via
facilitating JAK2-STAT3 pathway activation. J Neurooncol.
139:269–279. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren Z, Zou W, Cui J, Liu L, Qing Y and Li
Y: Geraniin suppresses tumor cell growth and triggers apoptosis in
human glioma via inhibition of STAT3 signaling. Cytotechnology.
69:765–773. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang K, Pang B, Xin T, Hou X, Jia J, Feng
B, Meng L, Xu S and Pang Q: Increased signal transducer and
activator of transcription 3 (STAT3) and decreased cyclin D1 in
recurrent astrocytic tumours compared with paired primary
astrocytic tumours. J Int Med Res. 39:2103–2109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang F, Wang Z, Yuan J, Wei X, Tian R and
Niu R: RNAi-mediated silencing of Anxa2 inhibits breast cancer cell
proliferation by downregulating cyclin D1 in STAT3-dependent
pathway. Breast Cancer Res Treat. 153:263–275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang T, Yuan J, Zhang J, Tian R, Ji W,
Zhou Y, Yang Y, Song W, Zhang F and Niu R: Anxa2 binds to STAT3 and
promotes epithelial to mesenchymal transition in breast cancer
cells. Oncotarget. 6:30975–30992. 2015.PubMed/NCBI
|
|
19
|
Lokman NA, Ween MP, Oehler MK and
Ricciardelli C: The role of Annexin A2 in tumorigenesis and cancer
progression. Cancer Microenviron. 4:199–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sharma MR, Koltowski L, Ownbey RT,
Tuszynski GP and Sharma MC: Angiogenesis-associated protein Annexin
II in breast cancer: Selective expression in invasive breast cancer
and contribution to tumor invasion and progression. Exp Mol Pathol.
81:146–156. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Inokuchi J, Narula N, Yee DS, Skarecky DW,
Lau A, Ornstein DK and Tyson DR: Annexin A2 positively contributes
to the malignant phenotype and secretion of IL-6 in DU145 prostate
cancer cells. Int J Cancer. 124:68–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shiozawa Y, Havens AM, Jung Y, Ziegler AM,
Pedersen EA, Wang J, Wang J, Lu G, Roodman GD, Loberg RD, et al:
Annexin II/Annexin II receptor axis regulates adhesion, migration,
homing, and growth of prostate cancer. J Cell Biochem. 105:370–380.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Villano JL, Seery TE and Bressler LR:
Temozolomide in malignant gliomas: Current use and future targets.
Cancer Chemother Pharmacol. 64:647–655. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maule F, Bresolin S, Rampazzo E, Boso D,
Della Puppa A, Esposito G, Porcù E, Mitola S, Lombardi G, Accordi
B, et al: Annexin 2A sustains glioblastoma cell dissemination and
proliferation. Oncotarget. 7:54632–54649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reeves SA, Chavez-Kappel C, Davis R,
Rosenblum M and Israel MA: Developmental regulation of Annexin II
(Lipocortin 2) in human brain and expression in high grade glioma.
Cancer Res. 52:6871–6876. 1992.PubMed/NCBI
|
|
26
|
Aukrust I, Hollas H, Strand E, Evensen L,
Travé G, Flatmark T and Vedeler A: The mRNA-binding site of Annexin
A2 resides in helices C-D of its domain IV. J Mol Biol.
368:1367–1378. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chiang Y, Rizzino A, Sibenaller ZA, Wold
MS and Vishwanatha JK: Specific down-regulation of Annexin II
expression in human cells interferes with cell proliferation. Mol
Cell Biochem. 199:139–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang HJ, Yao DF, Yao M, Huang H, Wang L,
Yan MJ, Yan XD, Gu X, Wu W and Lu SL: Annexin A2 silencing inhibits
invasion, migration, and tumorigenic potential of hepatoma cells.
World J Gastroenterol. 19:3792–3801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Guo B, Zhang Y, Cao J and Chen T:
Silencing of the Annexin II gene down-regulates the levels of
S100A10, c-Myc, and plasmin and inhibits breast cancer cell
proliferation and invasion. Saudi Med J. 31:374–381.
2010.PubMed/NCBI
|
|
30
|
Kumble KD, Hirota M, Pour PM and
Vishwanatha JK: Enhanced levels of annexins in pancreatic carcinoma
cells of Syrian hamsters and their intrapancreatic allografts.
Cancer Res. 52:163–167. 1992.PubMed/NCBI
|
|
31
|
Zhai H, Acharya S, Gravanis I, Mehmood S,
Seidman RJ, Shroyer KR, Hajjar KA and Tsirka SE: Annexin A2
promotes glioma cell invasion and tumor progression. J Neurosci.
31:14346–14360. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tatenhorst L, Rescher U, Gerke V and
Paulus W: Knockdown of annexin 2 decreases migration of human
glioma cells in vitro. Neuropathol Appl Neurobiol. 32:271–277.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Baldin V, Lukas J, Marcote MJ, Pagano M
and Draetta G: Cyclin D1 is a nuclear protein required for cell
cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou C, Ma J, Su M, Shao D, Zhao J, Zhao
T, Song Z, Meng Y and Jiao P: Down-regulation of STAT3 induces the
apoptosis and G1 cell cycle arrest in esophageal carcinoma ECA109
cells. Cancer Cell Int. 18:532018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rahaman SO, Harbor PC, Chernova O, Barnett
GH, Vogelbaum MA and Haque SJ: Inhibition of constitutively active
Stat3 suppresses proliferation and induces apoptosis in
glioblastoma multiforme cells. Oncogene. 21:8404–8413. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yuan J, Yang Y, Gao Z, Wang Z, Ji W, Song
W, Zhang F and Niu R: Tyr23 phosphorylation of Anxa2 enhances STAT3
activation and promotes proliferation and invasion of breast cancer
cells. Breast Cancer Res Treat. 164:327–340. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sansone P and Bromberg J: Targeting the
interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol.
30:1005–1014. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cui L, Song J, Wu L, Cheng L, Chen A, Wang
Y, Huang Y and Huang L: Role of Annexin A2 in the EGF-induced
epithelial-mesenchymal transition in human CaSki cells. Oncol Lett.
13:377–383. 2017. View Article : Google Scholar : PubMed/NCBI
|
